COVID-19 Response
Due to the COVID-19 pandemic, we are limiting in-person activities to research studies that received reactivation approval through the U-M Office of Research. Most study teams will continue to hold visits virtually or by telephone. All community events, wellness programs, and support groups will meet virtually at this time. For specific inquiries, please give us a call directly at 734-936-8803.
Center News
Dr. Annalise Rahman-Filipiak Receives Career Development Award from National Institute on Aging
We are pleased to announce that Dr. Annalise Rahman-Filipiak, a faculty member in our Leaders Initiative and current junior investigator mentee in our REC program, received a five-year K23 Mentored[…]
Dr. Alexandru Iordan awarded Alzheimer’s Association Research Fellowship
Dr. Alexandru D. Iordan, an affiliate of our Center and recent pilot project recipient, was recently awarded an Alzheimer’s Association Research Fellowship (AARF) which supports postdoctoral fellows engaged in Alzheimer’s[…]
Our latest edition of the Mind Matters newsletter
More information about our five years of funding from the National Institutes of Health, a new donor gift to support health disparities research in dementia, our registry that offers ongoing[…]
Federal Funding Renewed for Additional Five Years
August 23, 2021 Ann Arbor, MI – Federal funding has been confirmed to expand a collaboration between the University of Michigan, Michigan State University and Wayne State University that aims[…]
New research highlights important pathway for drug treatment in Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia
July 30, 2021 Ann Arbor, MI – The work of affiliates of the Michigan Alzheimer’s Disease Research Center captured the attention of the Journal of Biological Chemistry last week for[…]
Center MiNDSet Registry Offers Ongoing Research Opportunities for Older Adults and Caregivers
In addition to our Center’s main longitudinal research study, the University of Michigan Memory and Aging Project (UM-MAP), we invite anyone interested in participating in aging research studies to join[…]
Aducanumab Q&A (Aduhelm™)
Note: Aducanumab is not available at Michigan Medicine. In August 2021, the Pharmacy and Therapeutics committee voted against its use based on a review of the available information. What is aducanumab (Aduhelm™)?[…]
Our Statement on Aducanumab (Aduhelm)
June 7, 2021 On June 7th, the United States Food and Drug Administration (FDA) approved Aducanumab as a medication for Alzheimer’s disease. This is the first medication targeting Alzheimer’s disease[…]
Statewide Research Partnership
The Michigan Alzheimer's Disease Research Center (MADRC), an arm of our larger Michigan Alzheimer's Disease Center, is a partnership between the University of Michigan, Michigan State University, and Wayne State University to facilitate the most advanced dementia research.
Part of a National Research Network
The Michigan ADRC is funded by the National Institutes of Health and is one of 31 other Alzheimer's Disease Research Centers across the country.
